5 active warrant series; nearest expiry 2031-01-21.
Compare this book against every issuer →5 option grants covering 12,770,000 shares (~10% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.20 | Jan 21, 2031 1576d | 5.0M | OTM | 3.9% | C$1.0M | Auto |
| option | $1.03 | Apr 28, 2031 1673d | 4.2M | OTM | 3.3% | C$4.3M | Auto |
| option | $0.23 | Sep 21, 2032 2185d | 1.7M | OTM | 1.3% | C$391K | Auto |
| option | $0.34 | Mar 21, 2034 2731d | 570K | OTM | 0.4% | C$191K | Auto |
| option | $0.70 | Dec 9, 2035 3359d | 1.3M | OTM | 1.0% | C$910K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
128,281,096 shares outstanding, plus 0 from warrants and 12,770,000 from options — a fully diluted 141,051,096 shares, or ~10% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series; nearest expiry 2031-01-21.
Compare this book against every issuer →5 option grants covering 12,770,000 shares (~10% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.20 | Jan 21, 2031 1576d | 5.0M | OTM | 3.9% | C$1.0M | Auto |
| option | $1.03 | Apr 28, 2031 1673d | 4.2M | OTM | 3.3% | C$4.3M | Auto |
| option | $0.23 | Sep 21, 2032 2185d | 1.7M | OTM | 1.3% | C$391K | Auto |
| option | $0.34 | Mar 21, 2034 2731d | 570K | OTM | 0.4% | C$191K | Auto |
| option | $0.70 | Dec 9, 2035 3359d | 1.3M | OTM | 1.0% | C$910K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
128,281,096 shares outstanding, plus 0 from warrants and 12,770,000 from options — a fully diluted 141,051,096 shares, or ~10% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
